JLUpub
metadata only
CC BY 4.0
IRG1/itaconate rewires macrophage and lung tumor metabolism through G6PD inhibition
Tumor-associated macrophages (TAMs) possess both tumor-promoting and tumor-inhibiting roles. Here, we explore TAMs’ anti-tumor functions, focusing on the immune responsive gene 1 (IRG1) and its product, itaconate, in lung cancer development. Spatial metabolomics reveals that endogenous itaconate is
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A better understanding of cancer metabolism for a more efficient immunotherapy#1000705
- Targeted delivery platforms for in vivo immune cell engineering: emerging strategies for cancer immunotherapy.#1220890
- Characterization of Immune Evasion Mechanisms of Breast Cancer Disseminated Cells in the Lung#643559
- HIF-1α(+) CD4(+) T cells coordinate a tissue-resident immune cell network in the lung.#406454
- Protein tyrosine kinases in dendritic cell-mediated anti-cancer immunity#1146279
Record · ID 1500906
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive